Literature DB >> 32759367

Seeking Nonspecific Binding: Assessing the Reliability of Tissue Dilutions for Calculating Fraction Unbound.

William J Jusko1, Emilie A G Molins2, Vivaswath S Ayyar2.   

Abstract

It has become commonplace (270+ article citations to date) to measure the fraction unbound (FrUn) of drugs in tissue homogenates and diluted plasma and then use a Correction Factor Equation (CFE) to extrapolate to the undiluted state. The CFE is based on assumptions of nonspecific binding with experimental use of very low drug concentrations. There are several possible determinants of apparent nonspecific binding as measured by methods such as equilibrium dialysis: true macromolecule binding and lipid partitioning along with receptor, enzyme, and transporter interactions. Theoretical calculations based on nonlinear protein binding indicate that the CFE will be most reliable to obtain FrUn when added drug concentration is small, binding constants are weak, protein concentrations are relatively high, and tissue dilution is minimal. When lipid partitioning is the sole factor determining apparent tissue binding, the CFE should be perfectly accurate. Use of very low drug concentrations, however, makes it more likely that specific binding to receptors and other targets may occur, and thus FrUn may reflect some binding to such components. Inclusion of trapped blood can clearly cause minor to marked discrepancies from purely tissue binding alone, which can be corrected. Furthermore, assessment of the occurrence of ionization/pH shifts, drug instability, and tissue metabolism may be necessary. Caution is needed in the use and interpretation of results from tissue dilution studies and other assessments of nonspecific binding, particularly for very strongly bound drugs with very small FrUn values and in tissues with metabolic enzymes, receptors, and trapped blood. SIGNIFICANCE STATEMENT: The use of tissue, plasma, and cell preparations to help obtain fraction unbound and tissue-to-plasma partition coefficients in pharmacokinetics has grown commonplace, especially for brain. This report examines theoretical, physiological, and experimental issues that need consideration before trusting such measurements and calculations.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Year:  2020        PMID: 32759367      PMCID: PMC7497620          DOI: 10.1124/dmd.120.000118

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  49 in total

1.  Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.

Authors:  Patrick Poulin; Frank-Peter Theil
Journal:  J Pharm Sci       Date:  2002-05       Impact factor: 3.534

2.  General pharmacokinetic model for drugs exhibiting target-mediated drug disposition.

Authors:  D E Mager; W J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-12       Impact factor: 2.745

3.  Influence of lipophilicity and lysosomal accumulation on tissue distribution kinetics of basic drugs: a physiologically based pharmacokinetic model.

Authors:  K Yokogawa; J Ishizaki; S Ohkuma; K Miyamoto
Journal:  Methods Find Exp Clin Pharmacol       Date:  2002-03

4.  Quantitative modeling of selective lysosomal targeting for drug design.

Authors:  Stefan Trapp; Gus R Rosania; Richard W Horobin; Johannes Kornhuber
Journal:  Eur Biophys J       Date:  2008-05-27       Impact factor: 1.733

5.  Mathematical and Experimental Validation of Flux Dialysis Method: An Improved Approach to Measure Unbound Fraction for Compounds with High Protein Binding and Other Challenging Properties.

Authors:  J Cory Kalvass; Colin Phipps; Gary J Jenkins; Patricia Stuart; Xiaomei Zhang; Lance Heinle; Marjoleen J M A Nijsen; Volker Fischer
Journal:  Drug Metab Dispos       Date:  2018-02-02       Impact factor: 3.922

6.  A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.

Authors:  Robert J Riley; D F McGinnity; R P Austin
Journal:  Drug Metab Dispos       Date:  2005-06-02       Impact factor: 3.922

7.  Relative lipid content as the sole mechanistic determinant of the adipose tissue:blood partition coefficients of highly lipophilic organic chemicals.

Authors:  S Haddad; P Poulin; K Krishnan
Journal:  Chemosphere       Date:  2000-04       Impact factor: 7.086

8.  Investigation of the influence of FcRn on the distribution of IgG to the brain.

Authors:  Amit Garg; Joseph P Balthasar
Journal:  AAPS J       Date:  2009-07-28       Impact factor: 4.009

9.  Doxorubicin pharmacokinetics: Macromolecule binding, metabolism, and excretion in the context of a physiologic model.

Authors:  Daniel L Gustafson; Jeffrey C Rastatter; Tina Colombo; Michael E Long
Journal:  J Pharm Sci       Date:  2002-06       Impact factor: 3.534

10.  Steroid concentrations in plasma, whole blood and brain: effects of saline perfusion to remove blood contamination from brain.

Authors:  Matthew D Taves; Kim L Schmidt; Ilan M Ruhr; Katarzyna Kapusta; Nora H Prior; Kiran K Soma
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

View more
  1 in total

1.  Consideration of Fractional Distribution Parameter fd in the Chen and Gross Method for Tissue-to-Plasma Partition Coefficients: Comparison of Several Methods.

Authors:  Yoo-Seong Jeong; William J Jusko
Journal:  Pharm Res       Date:  2022-03-14       Impact factor: 4.580

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.